Table 1.
Baseline characteristics of the cohorts
| Aotearoa NZ discovery cohort |
Samoan replication cohorts |
Pacific Trust cohort |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NZ Māori | CI Māori | Samoan | Tongan | Niuēan | Pukapukan | Other/Mixed | Ngāti Porou Hauora | Samoan I | Samoan II | Samoan III | All | |
| Participants (n) | 814 | 172 | 322 | 155 | 37 | 72 | 232 | 270 | 2851 | 908 | 550 | 255 |
| Sex (male) n (%) | 459 (56.39) | 105 (61.05) | 235 (72.98) | 117 (75.48) | 28 (75.68) | 32 (44.44) | 143 (61.64) | 186 (68.89) | 1146 (40.2) | 406 (44.7) | 252 (45.8) | 126 (49.41) |
| Age range | 17–85 | 18–88 | 18–81 | 18–79 | 19–75 | 18–84 | 17–88 | 18–94 | 22–65 | 18–88 | 29–88 | 14–25 |
| Age distribution | 50.92 ± 15.36 | 50.97 ± 15.22 | 44.78 ± 14.18 | 42.17 ± 14.53 | 48.78 ± 13.62 | 44.93 ± 17.2 | 41.34 ± 15.69 | 56.15 ± 13.61 | 45.09 ± 11.18 | 43.26 ± 16.23 | 43.46 ± 8.74 | 18.49 ± 2.54 |
| Height (cm) | 170.31 ± 9.9 | 169.44 ± 10.43 | 173.57 ± 9.05 | 174.48 ± 8.65 | 172.13 ± 8.18 | 165.44 ± 9.57 | 171.74 ± 8.21 | 169.38 ± 8.68 | 165.2 ± 7.8 | 166.6 ± 8.1 | 165.4 ± 7.9 | 172.11 ± 8.95 |
| Weight (kg) | 95.58 ± 23.27 | 100.26 ± 24.53 | 106.04 ± 23.74 | 107.43 ± 20.92 | 98.49 ± 18.59 | 95.6 ± 20.4 | 104.07 ± 28.05 | 100.17 ± 24.81 | 91.3 ± 18.9 | 93.1 ± 22.7 | 87.6 ± 18.3 | 87.98 ± 20.28 |
| LDLa (mmol/L) | 2.74 ± 0.96 | 2.89 ± 0.96 | 2.91 ± 1.03 | 2.85 ± 1.05 | 2.89 ± 0.94 | 2.75 ± 1.1 | 2.78 ± 0.95 | 2.95 ± 1.06 | 3.4 ± 0.86) | 3.2 ± 0.90 | 3.6 ± 0.85 | 2.36 ± 0.64 |
| HDLa (mmol/L) | 1.18 ± 0.4 | 1.18 ± 0.38 | 1.12 ± 0.34 | 1.11 ± 0.37 | 1.1 ± 0.32 | 1.21 ± 0.23 | 1.15 ± 0.37 | 1.15 ± 0.3 | 1.2 ± 0.29) | 1.1 ± 0.26 | 1.0 ± 0.28 | 1.33 ± 0.32 |
| Gout, n (%) | 356 (43.95) | 91 (52.91) | 178 (55.97) | 79 (50.97) | 24 (64.86) | 15 (20.83) | 102 (43.97) | 170 (62.96) | – | – | – | 0 (0.0) |
| Type 2 diabetes, n (%) | 200 (27.47) | 53 (33.97) | 61 (21.79) | 35 (27.13) | 7 (24.14) | 19 (27.14) | 48 (22.64) | 62 (23.66) | 508 (17.8) | 87 (10.1) | – | 0 (0.0) |
The proportions with type 2 diabetes and gout are calculated from individuals without missing data.
Data are mean ± standard deviation or n (%), unless otherwise stated.
NZ, New Zealand; CI, Cook Islands.
Data were unavailable for lipid-lowering medications.